Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Phosphorylated tau; Ultrasonography; Plaque score; Mean flow velocity;
مقالات ISI آمیلوئید β (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آمیلوئید β; Alzheimer's disease; Biomarker; Driving; Driving cessation; Older adults; Aged; Preclinical; Cerebrospinal fluid; Amyloid β; Tau; ptau;
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Aloperine; Oxidative stress; Mitochondrial dysfunction; Apoptosis;
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Unfolded protein response; XBP1; Neurodegeneration; Aging;
Keywords: آمیلوئید β; AD; Alzheimer's disease; Aβ; amyloid-β; BBB; blood-brain barrier; CAs; cinnamic acid derivatives; CD; circular dichroism; DAPI; 4â²,6-diamidino-2-phenylindole; DMED; Dulbecco's modified Eagle's medium; DMSO; dimethylsulfoxide; HRMS; high resoluti
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; ADC; apparent diffusion coefficient; AFM; atomic force microscope; APC; antigen presenting cells; ApoE; apolipoprotein E; AQP4; aquaporin-4; BBB; blood brain barrier; BCSFB; blood-cerebrospinal fluid barrier;
Keywords: آمیلوئید β; Amyloid β; Alzheimer's disease; Akt; Long-term potentiation; Memory;
Keywords: آمیلوئید β; Amyloid β; Rosmarinic acid; Lipid peroxidation; Antioxidant system; Cholinergic system; Auditory event-related potential;
Keywords: آمیلوئید β; Alzheimer's disease; Reactive oxygen species; Oxidative stress; Amyloid β; Tau hyper- phosphorylation; Naturally occurring bioactive molecule;
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; AMPA; 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APP; amyloid precursor protein; AUD; alcohol use disorder; BZDs; benzodiazepines; EAATs; excitatory amino acid transporters; EW; ethanol withdrawal; GA
Keywords: آمیلوئید β; Amyloid β; Molecular dynamics simulations; Amylin; α-Synuclein; Tau; Aggregation;
Keywords: آمیلوئید β; 5-HT; 5-hydroxytryptamine; AA; arachidonic acid; ACh; acetylcholine; ACTH; adrenocorticotrophic hormone; AD; Alzheimer's Disease; ADP; adenosine diphosphate; Aβ; amyloid β; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepro
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; AEDs; antiepileptic drugs; BBB; blood-brain barrier; CNS; central nervous system; COX; cyclooxygenase; CSF; cerebrospinal fluid; EAE; experimental autoimmune encephalomyelitis; GABA; γ-aminobutyric acid; HAD; H
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Biomarkers; Cerebrospinal fluid; Immunotherapy; Monoclonal antibody; Pharmacokinetics; Pharmacodynamics; Phase-II study; Ponezumab;
Keywords: آمیلوئید β; Physical activity; Amyloid β; Genetics; Tau; Alzheimer's disease; Dementia;
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; APP; amyloid precursor protein; BF; basal forebrain; bvFTD; behavioral variant FTD; CBD; corticobasal degeneration; CSF; cerebrospinal fluid; DLB; dementia with Lewy bodies; DR; dorsal raphe; EDS; excessive daytim
Keywords: آمیلوئید β; Alzheimer's disease; Subjective cognitive decline; Cognitive complaint; Preclinical; Amyloid β; Florbetapir-PET; MRI; Atrophy; Hippocampus; Anxiety; Depression;
Keywords: آمیلوئید β; Alzheimer's disease; Genetics; Glymphatic system; Aquaporin-4; Amyloid β; Cognitive decline; Cohort study;
Keywords: آمیلوئید β; AD; Alzheimer's disease; Aβ; amyloid β; BDNF; brain-derived neurotrophic factor; CaMKII; calmodulin-dependent protein kinase II alpha; CBP; CREB-binding protein; CREB; cAMP response element-binding protein; DNMT; DNA methyl transferase; ERK1/2; extracel
Keywords: آمیلوئید β; Sleep; Neurofibrillary tangles; Amyloid β; Memory consolidation; Frontohippocampal; Default mode network; Attractor systems;
Keywords: آمیلوئید β; Amyloid β; Tau protein; Familial factor; Targeting; Metabolic dysfunction; Bionanomaterials;
Keywords: آمیلوئید β; Ferulic acid; Antioxidant; Inflammation; Neurodegenerative disorder; Cancer; Diabetes; Cardiomyopathy; AAPH; 2,2â²-azobis (2 amidinopropane) dihydrochloride; Aβ; Amyloid β; AD; Alzheimer's disease; AGE; Advanced glycation end product; ALP; Alkaline pho
Keywords: آمیلوئید β; AD; Alzheimer's disease; AMPD; adenosine monophosphate deaminase; ANA; antinuclear antibodies; ANCA; anticytoplasmatic antibodies; AP-1; activating protein 1; APC; antigen presenting cell; APP; amyloid precursor protein; Aβ; amyloid β; BACE-1; β-APP cl
Keywords: آمیلوئید β; Triterpene glycosides; Adjuvant; Cancer; Targeted toxins; Antimicrobial; Anti-inflammatory; Vaccines; QS-21; AD; Alzheimer's disease; AIDS; acquired immune deficiency syndrome; AS; adjuvant system; Aβ; amyloid β; APC; antigen presenting cells; Api; apio
Keywords: آمیلوئید β; 2,4-D; dichlorophenoxyacetic acid; [35S]TBPS; [35S]tertiary-butylbicyclophosphorothionate; 3-NP; 3-nitropropionic acid; 4CL; 4-coumarate: CoA ligase; 4-O-MH; 4-O-methylhonokiol; 6-OHDA; 6-hydroxydopamine; 8-oxo-dG; 8-oxo-2â²-deoxyguanosine; AChE; acetylc
Keywords: آمیلوئید β; Idiopathic normal pressure hydrocephalus; Alzheimer's disease; Amyloid-beta; Total tau protein; Lumbo-peritoneal shunt surgery; Treatment; NPH; normal pressure hydrocephalus; iNPH; idiopathic NPH; AD; Alzheimer's disease; iNPH/ADÂ +; Â iNPH patients with
Keywords: آمیلوئید β; Aβ; amyloid β; AA; arachidonic acid; AD; Alzheimer's disease; ALA; α-linolenic acid; APP; amyloid precursor proteins; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CSF; cerebral spinal fluid; COX2; cyclooxygenase 2; DHA; docosah
Keywords: آمیلوئید β; α-epoxy; 5α,6α-epoxycholesterol; β-epoxy; 5β,6β-epoxycholesterol; 24-OH; 24-hydroxycholesterol; 25-OH; 25-hydroxycholesterol; 27-OH; 27-hydroxycholesterol; 4β-OH; 4β-hydroxycholesterol; 7β-OH; 7β-hydroxycholesterol; 7α-OH; 7α-hydroxycholestero
Keywords: آمیلوئید β; AChE; Acetylcholinesterase; AChR; Acetylcholine Receptor; ALG13,14; UDP-N-acetylglucosaminyltransferase subunit 13, 14; AMDHD2; Amidohydrolase domain containing 2; ATP; Adenosine triphosphate; Aβ; Amyloid β; CDG; Congenital disorders of glycosylation; C
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; APP transgenic mice; DAL mice; Oxidative stress;
Keywords: آمیلوئید β; HIBM; hereditary inclusion-body myopathy; s-IBM; sporadic inclusion-body myositis; GNE; UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase; GNE/MNK; UDP-GlcNAc 2-epimerase/ManNAc kinase; DMRV; distal myopathy with rimmed vacuoles; CK; creatine
Keywords: آمیلوئید β; Alzheimer's disease; Astrocyte; GLT-1; Tau; Amyloid β;
Keywords: آمیلوئید β; Aβ; amyloid β; AChEI; acetylcholinesterase inhibitor; AD; Alzheimer's disease; nAChR; nicotinic acetylcholine receptor; Neuroprotection; Nicotinic; Multi-target-directed ligands; Multifunctional compounds; Amyloid; Glutamate; Excitotoxicity; Neurodege
Keywords: آمیلوئید β; Amyloid β; Tau; Vaccination; Immunomodulation; Alzheimer's disease; Transgenic mice;
Keywords: آمیلوئید β; AD; Alzheimer's disease; Aβ; amyloid β; Aph-1; anterior pharynx defective 1; AP; adaptor protein; APOE; apolipoprotein E; APP; amyloid precursor protein; AICD; amyloid intracellular domain; BACE-1; β-secretase beta-site amyloid precursor protein-cleavi
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; AR; androgen receptor; BICD; Bicaudal D; BDNF; brain-derived neurotrophic factor; BMP; bone morphogenetic protein; CAV2; Canine Adenovirus 2; CMT
Keywords: آمیلوئید β; Extracellular alpha-synuclein; Oxidative stress; “Prion-like” protein transmission; Nitric oxide; Mitochondria dysfunction; Neurodegenerative diseases; OH; hydroxyl radicals; AD; Alzheimer's disease; ASN; α-synuclein; Aβ; amyloid β; CaN; calcineu
Keywords: آمیلوئید β; Aβ; amyloid β; AD; Alzheimer's disease; APP; amyloid precursor protein; ERK1/2; extracellular signal-regulated kinases; H2S; hydrogen sulfide; JNK; c-jun N-terminal kinases; MAPK; mitogen-activated protein kinases; MDA; malondialdehyde; NaHS; sodium h
Keywords: آمیلوئید β; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ANOVA; Analysis of variance; Aβ; amyloid β; bHLH; basic Helix-Loop-Helix; C4; complement C4; CLEAR; coordinated lysosomal expression and regulation; Cyba; cytochrome b-245 light chain; DW; d
Keywords: آمیلوئید β; Aβ; amyloid β; AADC; L-amino acid decarboxylase; ACC; Anterior cingulate cortex; AD; Alzheimer's disease; aMCI; Amnestic mild cognitive impairment; APP; Amyloid precursor protein; AR; Adrenergic receptor; ATMX; atomoxetine; BDNF; Brain-derived neurotrop
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Amyloid precursor protein; Secretase;
Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1-42 in Alzheimer's Disease Neuroimaging Initiative participants
Keywords: آمیلوئید β; Amyloid β; Aβ1-42; Alzheimer's disease; Cerebrospinal fluid (CSF); Type 2 diabetes mellitus;
Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults
Keywords: آمیلوئید β; SUMO; Alzheimer's disease; Amyloid β; Hydrogen peroxide; Glutamate;
Gamma-linolenic acid ameliorates Aβ-induced neuroinflammation through NF-κB and MAPK signalling pathways
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Gamma-linolenic acid; Inflammation; NF-κB;
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people
Keywords: آمیلوئید β; Cerebral hypoperfusion; amyloid β; Alzheimer's disease; Pathogenesis; Tau;
Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway
Keywords: آمیلوئید β; DSS; Dangguishaoyao-San; AD; Alzheimer's disease; LPS; lipopolysaccharide; Aβ; amyloid β; NF-κB; nuclear factor κB; IκB; inhibitor of NF-κB; TLR-2; toll-like receptor-2; TLR-4; toll-like receptor-4; TNF-α; tumor necrosis factor-α; iNOS; inducibl
Aβ1-42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells
Keywords: آمیلوئید β; Alzheimer's disease; Amyloid β; Blood-brain barrier; Autophagy; Receptor for Advanced Glycation End Products (RAGE); Tight junctions;
Chronic benzodiazepine suppresses translocator protein and elevates amyloid β in mice
Keywords: آمیلوئید β; AD; Alzheimer's disease; Aβ; amyloid β; cBZD; chronic benzodiazepine; MMS; mitochondrial membrane swelling; TSPO; translocator protein; PS1; presenilin-1; ROS; reactive O2 species;
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested
Keywords: آمیلوئید β; Alzheimer's disease; Neurodegenerescence; Memory; Neuroinflammation; Amyloid β; Phosphorylated tau; Photobiomodulation; Electromagnetic; LLLT; Magnetic; Photonic; Oxidative stress;
miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors
Keywords: آمیلوئید β; Aβ; amyloid β; ACSF; artificial cerebrospinal fluid; AD; Alzheimer's disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANOVA; analysis of variance; APP; amyloid precursor protein; BACE1; beta-secretase 1; BSA; bovine serum albumin;